Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Hepatology Communications|May 22, 2026
Reduced wait times for hepatology referrals in a prospective quality improvement initiativeOfodile Joe-Uzuegbu, Yashasavi Sachar, Abdel Aziz Shaheen, et al.
Journal of Hepatology|March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infectionEdward J Gane, Young-Suk Lim, Stuart C Gordon, et al.
Hepatology Communications|December 3, 2025
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trialSanam Tabataba Vakili, Grishma Hirode, Atif Zahoor, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2020
Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North AmericaGolasa Samadi Kochaksaraei, Eliana Castillo, Matthew D Sadler, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2024
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 studyHarry L A Janssen, Young-Suk Lim, Pietro Lampertico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorJennifer C C Hu, Robert S Coffin, Ceri J Davis, et al.
Journal of Viral Hepatitis|August 16, 2024
Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B-Related Hepatocellular CarcinomaY Sachar, S E Congly, K W Burak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis BMan-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Journal for Immunotherapy of Cancer|August 8, 2018
White paper on microbial anti-cancer therapy and preventionNeil S Forbes, Robert S Coffin, Liang Deng, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infectionHarry L Janssen, Young-Suk Lim, Hyung Joon Kim, et al.
Pageof 24